Thus, even though loss of EEPD1 results in genomic instability, EEPD1 should not be viewed as a tumor suppressor in the same sense as BRCA1 and BRCA2, two HR components that show loss of function mutations in cancer. Here, BRCA2 is linked to neoplasm.